Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Apexigen Raises $73m In Series B And Series C Financings
Venture Capital

Apexigen Raises $73m In Series B And Series C Financings

by posted 1year ago 50 views
Apexigen Raises $73 Million In Series B And Series C Financings-- Proceeds to Support Ongoing Phase 2 Clinical Trials of Immuno-oncology Therapeutic APX005M and the Discovery and Development of a Pipeline of Novel Therapies -- SAN CARLOS, Calif., August 8, 2018-- Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced the successful completion of its Series B and Series C financings in which it raised a total of $73 million. The $15 million Series B financing was led by Decheng Capital and the recent $58 million Series C financing was led by 3E Bioventures Capital, Virtus Inspire Ventures, and SV Tech Ventures.

In this article